» Articles » PMID: 35005602

Point-prevalence Surveys of Antimicrobial Consumption and Resistance at a Paediatric and an Adult Tertiary Referral Hospital in Yangon, Myanmar

Overview
Date 2022 Jan 10
PMID 35005602
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Antimicrobial resistance is increasingly prevalent worldwide. The inappropriate use of antimicrobials, including in the hospital setting, is considered a major driver of antimicrobial resistance.

Aim: To inform improvements in antimicrobial stewardship, we undertook point prevalence surveys of antimicrobial prescribing at Yangon Children's Hospital and Yangon General Hospital in Yangon, Myanmar.

Methods: We conducted our surveys using the Global Point-Prevalence Survey of Antimicrobial Consumption and Resistance (Global-PPS) method. All inpatients who were prescribed an antimicrobial on the day of the survey were included in the analysis.

Findings: We evaluated a total of 1,980 patients admitted to two hospitals during December 2019. Of these, 1,255 (63.4%) patients were prescribed a total of 2,108 antimicrobials. Among antimicrobials prescribed, 722 (34.3%) were third-generation cephalosporins, the most commonly prescribed antimicrobial class. A total of 940 (44.6%) antimicrobials were prescribed for community-acquired infection, and 724 (34.3%) for surgical prophylaxis. Of 2,108 antimicrobials, 317 (15.0%) were prescribed for gastrointestinal tract prophylaxis, 305 (14.5%) for skin, soft tissue, bone and joint prophylaxis, and 303 (14.4%) for pneumonia treatment. A stop or review date was documented for 350 (16.6%) antimicrobial prescriptions, 673 (31.9%) antimicrobial prescriptions were guideline compliant, and 1,335 (63.3%) antimicrobials were administered via the parenteral route. Of 1,083 antimicrobials prescribed for a therapeutic use, 221 (20.4%) were targeted therapy.

Conclusion: Our findings underscore the need to update and expand evidence-based guidelines for antimicrobial use, promote the benefits of targeted antimicrobial therapy, and support the implementation of hospital-based antimicrobial stewardship programmes at the hospitals surveyed.

Citing Articles

Identifying targets for antibiotic stewardship interventions in pediatric patients in Punjab, Pakistan: point prevalence surveys using AWaRe guidance.

Sheikh S, Saleem Z, Afzal S, Qamar M, Raza A, Haider Naqvi S Front Pediatr. 2025; 12:1469766.

PMID: 39867700 PMC: 11759272. DOI: 10.3389/fped.2024.1469766.


Antimicrobial Use Among Hospitalized Neonates and Children; Findings and Implications from a Comprehensive Point Prevalence Survey Among General Tertiary Hospitals in Pakistan.

Ul Mustafa Z, Salman M, Khan A, Harun S, Meyer J, Godman B Infect Drug Resist. 2024; 17:5411-5428.

PMID: 39664724 PMC: 11631696. DOI: 10.2147/IDR.S491454.


A longitudinal point prevalence survey of antimicrobial use and resistance in tertiary care hospitals in Kerman: results from the national Iranian multicenter point prevalence survey of antimicrobials in 2021.

Hosseininasab A, Barshan F, Farsiu N, Nakhaie M, Soltani J, Versporten A BMC Infect Dis. 2024; 24(1):1300.

PMID: 39543480 PMC: 11566745. DOI: 10.1186/s12879-024-10159-9.


Antimicrobial use in hospitalized patients: a point prevalence survey across four tertiary hospitals in Niger.

Tapha O, Degbey C, Yacouba A, Mahouna Tchioundjro E, Nadakou N, Alkassoum Salifou I JAC Antimicrob Resist. 2024; 6(5):dlae175.

PMID: 39478985 PMC: 11523492. DOI: 10.1093/jacamr/dlae175.


Antibiotic prescribing and bacterial infection in COVID-19 inpatients in Southeast Asia: a systematic review and meta-analysis.

Chanapal A, Cheng H, Lambert H, Cong W JAC Antimicrob Resist. 2024; 6(3):dlae093.

PMID: 38863558 PMC: 11166085. DOI: 10.1093/jacamr/dlae093.


References
1.
Mendelson M, Matsoso M . The World Health Organization Global Action Plan for antimicrobial resistance. S Afr Med J. 2015; 105(5):325. DOI: 10.7196/samj.9644. View

2.
Middleton J . Public health in England in 2016-the health of the public and the public health system: a review. Br Med Bull. 2017; 121(1):31-46. DOI: 10.1093/bmb/ldw054. View

3.
Murthy R . Implementation of strategies to control antimicrobial resistance. Chest. 2001; 119(2 Suppl):405S-411S. DOI: 10.1378/chest.119.2_suppl.405s. View

4.
Leaper D, Edmiston C . World Health Organization: global guidelines for the prevention of surgical site infection. J Hosp Infect. 2017; 95(2):135-136. DOI: 10.1016/j.jhin.2016.12.016. View

5.
Leaper D, Burman-Roy S, Palanca A, Cullen K, Worster D, Gautam-Aitken E . Prevention and treatment of surgical site infection: summary of NICE guidance. BMJ. 2008; 337:a1924. DOI: 10.1136/bmj.a1924. View